Join for free and connect with our local tech scene

Stay on top of the latest companies and upcoming events with our weekly newsletter, and be counted among the people building the future of your local tech community.

Rochester, NY /

Partnering with the National Cancer Institute: How to Access Therapeutic Development and Moonshot Resources

Central Library of Rochester & Monroe County Rundel Building Harold Hacker Hall 115 South Avenue Rochester, NY 14604 (map)

The Chester F. Carlson Patent & Trademark Center at the Central Library of Rochester & Monroe County is hosting a talk the talk “Partnering with the NCI:  How to Access Therapeutic Development and Moonshot Resources on Thursday,” on Thursday, June 14th from 6 to 8:30pm.  The speaker, Jason Cristofaro, PhD, JD, is an intellectual property attorney with the National Cancer Institute (NCI).  Dr. Cristofaro’s work has focused on implementing intellectual property policy to the development of novel anticancer therapeutic agents, with a particular focus on enabling innovative public-private partnerships.  Networking and cocktails are from 6 to 7 p.m., Dr. Cristofaro will speak from 7 to 8p.m., followed by a half hour question and answer session.

This program is sponsored by the Breast Cancer Coalition of Rochester, the UR Medicine Wilmot Cancer Institute, the Rochester Regional Health Lipson Cancer Institute, the Pluta Cancer Center Foundation, and the Friends & Foundation of the Rochester Public Library

Dr. Cristofaro joined NCI’s Division of Cancer Treatment and Diagnosis (DCTD) in 2007 after completing a two-year Presidential Management Fellowship. During his tenure, Dr. Cristofaro’s work has focused on implementing intellectual property policy to support DCTD’s core function of advancing the development of novel anticancer therapeutic agents, with a particular focus on enabling innovative public-private partnerships. Major projects have included revising the division’s policy for managing internal Cooperative Research and Development Agreements (CRADAs), developing a consistent standard for determining monetary contributions of CRADA partners, revising and implementing DCTD contractual agreements for screening potential anticancer compounds, revising the Intellectual Property Option of the Cancer Therapy Evaluation Program, and developing and vetting the overall contractual agreement structures for the NCI Experimental Therapeutics program (NExT), the MATCH initiative and the NCI formulary.  Dr. Cristofaro currently serves as Intellectual Property Program Manager for the DCTD and as Alternate Technology Development Coordinator for the NCI. He received his Ph.D. in Microbiology from the University of Maryland and his J.D. from Georgetown University.

This event is free, but registration is required.  To register for the event please go to: http://calendar.libraryweb.org/event/4149693

Submitted by

Avatar_default_20 Jennifer Byrnes

Comments

Sign in to comment.